Results 1 - 10 of 71
[PROJECT] ANTIFLU - Innovative anti-influenza drugs excluding viral escape
ID: 259842
Start date: 2011-06-01, End date: 2016-11-30
ANTIFLU is to develop innovative drugs against influenza virus infections based on a novel concept that precludes the development of viral resistance and ensures efficacy against upcoming pandemic influenza strains. Viral replication is known to depend on multiple host factor...
Programme: FP7-HEALTH
Record Number: 99759
Last updated on: 2017-05-26
[PROJECT] STOPENTERICS - Vaccination against Shigella and ETEC: novel antigens, novel approaches
ID: 261472
Start date: 2010-11-01, End date: 2017-12-31
To contribute to the development of vaccines against Shigella and ETEC for children of the developing world, STOPENTERICS will provide novel solutions by imposing a two-fold paradigm switch: (i) to break the dogma of serotype-specificity by inducing a cross-protective immunit...
Programme: FP7-HEALTH
Record Number: 97173
Last updated on: 2017-07-02
[REPORT SUMMARY] Final Report Summary - CRYOPRESERVATION (Improved Cryopreservation using Ice Binding Proteins)
Cryopreservation is the use of low temperatures to preserve biological samples. The ability to store biological materials without damaging them has taken on increasing importance in the face of a shortage of organs for transplantation. While preservation by freezing seems...
Programme: FP7-IDEAS-ERC
Record Number: 194689
Last updated on: 2017-02-09
[PROJECT] CRYOPRESERVATION - Improved Cryopreservation using Ice Binding Proteins
ID: 281595
Start date: 2011-11-01, End date: 2016-10-31
Several organisms have evolved specialized ice binding proteins (IBPs) that prevent their body fluids from freezing (antifreeze proteins, AFPs), inhibit recrystallization of ice in frozen tissues, or initiate freezing at moderate supercooling temperatures (ice nucleating prot...
Programme: FP7-IDEAS-ERC
Record Number: 101006
Last updated on: 2017-07-02
[PROJECT] FIT FOR HEALTH - Promoting participation of high-tech research-intensive SMEs in Health
ID: 260748
Start date: 2010-10-01, End date: 2013-09-30
Fit for Health aims to sustainably enhance the participation of European small or medium-sized enterprises (SMEs) in Calls for the FP7 Health Theme. Focusing on research-intensive, high technology SMEs, the project offers targeted support measures, covering the entire innovat...
Programme: FP7-HEALTH
Record Number: 96688
Last updated on: 2017-05-26
[PROJECT] SYSCOL - Systems Biology of Colorectal Cancer
ID: 258236
Start date: 2011-01-01, End date: 2015-12-31
Colorectal cancer (CRC) is one of the most common cancers in both males and females, and it is perhaps the best understood of all epithelial tumors in terms of its molecular origin. Yet, despite large amount of work that has concentrated on understanding of colon tumorigenesi...
Programme: FP7-HEALTH
Record Number: 97658
Last updated on: 2017-05-29
[PROJECT] EPIGENESYS - Epigenetics towards systems biology
ID: 257082
Start date: 2010-10-01, End date: 2016-03-31
The ‘EpiGeneSys’ Network of Excellence aims to enable European epigenetics research to enter the arena of systems biology, a new step forward with major implications for human health. Many diseases, not explained solely by gene mutation, have rather been associated with epige...
Programme: FP7-HEALTH
Record Number: 97509
Last updated on: 2017-05-29
[PROJECT] HEMIBIO - HEPATIC MICROFLUIDIC BIOREACTOR
ID: 266777
Start date: 2011-01-01, End date: 2015-12-31
The goal of HeMiBio is to develop a hepatic microfluidic bioreactor from human iPSC-derived hepatocytes, hepatic sinusoidal endothelial cells (HSEC) and stellate cells (HSC), suitable for inclusion in a repeated dose toxicity testing strategy of pharmaceuticals/cosmetic ingre...
Programme: FP7-HEALTH
Record Number: 105662
Last updated on: 2017-06-12
[REPORT SUMMARY] Final Report Summary - RUBICAN (RNF20 and H2B ubiquitination: linking chromatin dynamics, transcriptional control and cancer)
Chromatin modifications are emerging as major regulators of gene expression. Notably, numerous chromatin modifications have been found to be deregulated in cancer, and some of them have been causally related to cancer progression. In our study, we focused on one particular...
Programme: FP7-IDEAS-ERC
Record Number: 197307
Last updated on: 2017-04-11
[REPORT SUMMARY] Mid-Term Report Summary - MUDLOC (Multi-Dimensional Lab-On-Chip)
MuDLOC is a multi-dimensional microfluidic based platform for proteomics. The core technology of MuDLOC is a DNA to protein array. This means that a DNA array is turned into a protein by in vitro transcription and translation inside the device, at nanoliter volumes. The...
Programme: FP7-IDEAS-ERC
Record Number: 181994
Last updated on: 2016-05-05
List retrieved on: 2017-08-02
